Tags | Domains | Searches | Statistics | Options | Advanced Search
|
Tags | Domains | Searches | Statistics | Options | Advanced Search |
![Teva Buys Barr Pharmaceuticals [PharmaGazette]](http://imageserver.news.speeple.com/1/b/5/d/f/6/d/e/1/a/4966d71d04ec939bafd9bb.jpeg) |
Teva Buys Barr Pharmaceuticals [PharmaGazette]Know More Media - Health Care / Pharmaceutical / Fitness - Jul 19, 2008 The Isreali based Teva Pharmaceuticals has agreed to purchase Barr Pharmaceuticals, of New Jersey for approximately $7.5 billion and in addition will assume $1.5 billion in debt. Both companies are manufacturers of … Also tagged: buyout, barr pharmaceuticals, teva pharmaceuticals |
|
Teva Buys Barr PharmaceuticalsPharmaGazette - Jul 19, 2008 The Isreali based Teva Pharmaceuticals has agreed to purchase Barr Pharmaceuticals, of New Jersey for approximately $7.5 billion and in addition will assume $1.5 billion in debt. Both companies are manufacturers of … Also tagged: buyout, barr pharmaceuticals, teva pharmaceuticals |
 |
GlaxoSmithKline Acquires Reliant PharmaceuticalsPharmaGazette - Dec 20, 2007 GlaxoSmithKline (NYSE: GSK ) has acquired Reliant Pharmaceuticals following the US Federal Trade Commission's early termination of the waiting period required by U.S. anitrust law. The acquisition adds Reliant's … Also tagged: glaxosmithkline, gsk, acquisition, lovaza |
|
GlaxoSmithKline Acquires Reliant Pharmaceuticals [PharmaGazette]Know More Media - Health Care / Pharmaceutical / Fitness - Dec 20, 2007 GlaxoSmithKline (NYSE: GSK ) has acquired Reliant Pharmaceuticals following the US Federal Trade Commission's early termination of the waiting period required by U.S. anitrust law. The acquisition adds Reliant's … Also tagged: glaxosmithkline, gsk, acquisition |
![Bristol-Meyer Squibb Acquires Adenxus Therapeutics [PharmaGazette]](http://imageserver.news.speeple.com/e/b/c/0/3/e/c/f/7/0/1e324961e7e5f87a477583.jpeg) |
Bristol-Meyer Squibb Acquires Adenxus Therapeutics [PharmaGazette]Know More Media - Health Care / Pharmaceutical / Fitness - Sep 24, 2007 It was announced today that Bristol-Meyer Squibb and Adnexus Therapeutics have an agreement where Bristol-Meyers will acquire Adnexus. Adnexus Therapeutics, a privately held company, is the developer of a new … Also tagged: acquisition, bristol myers squibb, adnexus |
|
Bristol-Meyer Squibb Acquires Adenxus TherapeuticsPharmaGazette - Sep 24, 2007 It was announced today that Bristol-Meyer Squibb and Adnexus Therapeutics have an agreement where Bristol-Meyers will acquire Adnexus. Adnexus Therapeutics, a privately held company, is the developer of a new … Also tagged: acquisition, bristol myers squibb |
 |
Evotec AG Acquires U.S Based Renovis Inc.PharmaGazette - Sep 20, 2007 Germany based pharmaceuticals company, Evotec AG, announced Wednesday that it will be buying the American company Renovis Inc. The deal, worth $151.8M USD will increase Evotec's research ability into treatments for … Also tagged: acquisition, evotec, pharmaceutical company, renovis |
|
Evotec AG Acquires U.S Based Renovis Inc. [PharmaGazette]Know More Media - Health Care / Pharmaceutical / Fitness - Sep 20, 2007 Germany based pharmaceuticals company, Evotec AG, announced Wednesday that it will be buying the American company Renovis Inc. The deal, worth $151.8M USD will increase Evotec's research ability into treatments for … Also tagged: acquisition, evotec, pharmaceutical company |
 |
Bayer Healthcare and Intendis Collaborates to Promote Yaz® for Moderate Acne TreatmentPharmaGazette - Jul 10, 2007 Bayer HealthCare Pharmaceuticals Inc. and Intendis Inc. will co-promote YAZ® (drospirenone/ethinyl estradiol) as a treatment for moderate acne in women who desire an oral contraceptive for birth control. The said … Also tagged: contraceptive, drug marketing, pmdd, yaz, bayer healthcare, bayer pharmaceuticals inc, bayer schering pharma ag, intendis inc |
 |
Victory Pharma, Inc. Completed Acquisition of Naprelan®PharmaGazette - Jul 10, 2007 Victory Pharma, Inc. (Victory) has recently completed the acquisition of the exclusive US marketing rights to its leading marketed pain product, Naprelan®, wherein Victory paid total consideration of $8.75 million to … Also tagged: drug marketing, pain reliever, elan corporation, naprelan, naproxen sodium, victory pharma |